Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty
Publication
, Journal Article
TCHENG, J
Published in: Circulation
1994
Duke Scholars
Published In
Circulation
Publication Date
1994
Volume
90
Start / End Page
1757 / 1764
Related Subject Headings
- Cardiovascular System & Hematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
TCHENG, J. (1994). Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty. Circulation, 90, 1757–1764.
TCHENG, J. E. “Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty.” Circulation 90 (1994): 1757–64.
TCHENG J. Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty. Circulation. 1994;90:1757–64.
TCHENG, J. E. “Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty.” Circulation, vol. 90, 1994, pp. 1757–64.
TCHENG J. Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty. Circulation. 1994;90:1757–1764.
Published In
Circulation
Publication Date
1994
Volume
90
Start / End Page
1757 / 1764
Related Subject Headings
- Cardiovascular System & Hematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology